Arcturus Therapeutics Holdings Inc. Revenue 2018–2025
Arcturus Therapeutics Holdings Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Arcturus Therapeutics Holdings Inc. revenue for the quarter ending March 31, 2026 was 2.1 M, a 92.99% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. revenue for the twelve months ending March 31, 2026 was 76.9 M, a 55.98% decrease year-over-year.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2025 was 82.0 M, a 46.14% decrease from 2024.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2024 was 152.3 M, a 8.69% decrease from 2023.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2023 was 166.8 M, a 19.03% decrease from 2022.
- Arcturus Therapeutics Holdings Inc. annual revenue for 2022 was 206.0 M.
Arcturus Therapeutics Holdings Inc. (ARCT) — Frequently Asked Questions
Arcturus Therapeutics Holdings Inc. (ARCT) is a publicly traded US company. It has a market capitalization of $189M. In fiscal 2025 it reported revenue of $82M and net income of -$66M. Explore ARCT's stock price, financial statements, earnings history, margins and key ratios below.
What is Arcturus Therapeutics Holdings Inc.'s market cap?
Arcturus Therapeutics Holdings Inc. (ARCT) has a market capitalization of $189M.
What is the ARCT stock price?
ARCT trades at $6.89 (-3.77% on the day).
How much revenue does Arcturus Therapeutics Holdings Inc. make?
Arcturus Therapeutics Holdings Inc. reported revenue of $82M in fiscal 2025.
Is ARCT profitable?
In fiscal 2025, Arcturus Therapeutics Holdings Inc. reported net income of -$66M.